Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-25-058531
Filing Date
2025-06-11
Accepted
2025-06-11 16:05:37
Documents
15
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2517714d2_10ka.htm   iXBRL 10-K/A 83725
2 EXHIBIT 4.5 tm2517714d2_ex4-5.htm EX-4.5 36061
3 EXHIBIT 31.1 tm2517714d2_ex31-1.htm EX-31.1 4099
4 EXHIBIT 31.2 tm2517714d2_ex31-2.htm EX-31.2 4073
  Complete submission text file 0001104659-25-058531.txt   356722

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA aeon-20241231.xsd EX-101.SCH 3029
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE aeon-20241231_lab.xml EX-101.LAB 36883
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aeon-20241231_pre.xml EX-101.PRE 24155
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2517714d2_10ka_htm.xml XML 6541
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40021 | Film No.: 251039951
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)